Statement Of Cash Flows [Abstract]

Transgene - Filing #833175

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
7 719 EUR
2 900 EUR
Cash flows from (used in) operations before changes in working capital
27 606 EUR
25 393 EUR
Adjustments for increase (decrease) in deferred income including contract liabilities [abstract]
Adjustments for increase (decrease) in deferred income including contract liabilities
944,000 EUR
804,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
- EUR
- EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.